Davis, United States
Bindkin Bio is a biotechnology startup founded in 2018 and headquartered in the United States. The company specializes in providing high-throughput, real-time binding kinetics data for various drug discovery purposes. Its slogan "Binding Kinetics in Real Time" emphasizes its core competency.
Bindkin Bio serves as a Contract Research Organization (CRO), supporting clients' drug discovery endeavors by supplying experimental data crucial for computational drug-target predictions. This capacity positions the company at the intersection of biotechnology, pharmaceuticals, and data-driven drug development.
As of now, there is no public information available on the company's last investment or its associated investors. While Bindkin Bio operates in a niche yet critical segment of the biotechnology industry, attracting investor interest could be essential for scaling its operations and staying ahead in the competitive drug discovery landscape.
